7790-28-5

Usage

InChI:InChI=1/HIO4.Na/c2-1(3,4)5;/h(H,2,3,4,5);/q;+1/p-1

Synthetic route

iodine (7553-56-2) + sodium hydroxide (1310-73-2) → sodium periodate (7790-28-5)

Conditions	Yield
In not given Electrolysis; NaOH soln. as catholyte and NaOH soln. of I2 as anolyte are separated by permeable diaphragm, PbO2 anode, current density : 0.05-0.3 A/cm2, acidifying of anodic soln.; crystn. at 37°C;
In not given Electrolysis; NaOH soln. as catholyte and NaOH soln. of I2 as anolyte are separated by permeable diaphragm, PbO2 anode, current density : 0.05-0.3 A/cm2, acidifying of anodic soln.; crystn. at 37°C;

iodine (7553-56-2) + chlorine (7782-50-5) + sodium hydroxide (1310-73-2) → sodium periodate (7790-28-5)

Conditions	Yield
In water passing gaseous Cl2 through a soln. of 20 g I and 80 g NaOH in 300 ml water; crystallization after some hours;; filtration; washing; repeated recrystallization from diluted H2SO4;;

Sodium borate + iodine (7553-56-2) → sodium periodate (7790-28-5)

Conditions	Yield
In not given Electrolysis; NaOH soln. as catholyte and NaOH soln. of I2 as anolyte are separated by permeable diaphragm, PbO2 anode, current density : 0.05-0.3 A/cm2, acidifying of anodic soln.; crystn. at 37°C;
In not given Electrolysis; NaOH soln. as catholyte and NaOH soln. of I2 as anolyte are separated by permeable diaphragm, PbO2 anode, current density : 0.05-0.3 A/cm2, acidifying of anodic soln.; crystn. at 37°C;

iodine (7553-56-2) + sodium sulfate (7757-82-6) → sodium periodate (7790-28-5)

Conditions	Yield
In not given Electrolysis; NaOH soln. as catholyte and NaOH soln. of I2 as anolyte are separated by permeable diaphragm, PbO2 anode, current density : 0.05-0.3 A/cm2, acidifying of anodic soln., neutralization with NaOH soln; crystn. at 37°C;
In not given Electrolysis; NaOH soln. as catholyte and NaOH soln. of I2 as anolyte are separated by permeable diaphragm, PbO2 anode, current density : 0.05-0.3 A/cm2, acidifying of anodic soln., neutralization with NaOH soln; crystn. at 37°C;

sodium peroxide + sodium iodide (7681-82-5) → sodium periodate (7790-28-5)

Conditions	Yield
In neat (no solvent) reaction when heating;;

sodium paraperiodate → sodium periodate (7790-28-5)

Conditions	Yield
With nitric acid In water concd. HNO3 soln. used, standing for 24 h at ambient temp.; washing more times with cold water, drying at 110°C;
With HNO3 In water concd. HNO3 soln. used, standing for 24 h at ambient temp.; washing more times with cold water, drying at 110°C;
With HNO3 In water

sodium periodate trihydrate → sodium periodate (7790-28-5)

Conditions	Yield
In water formation by recrystallization of NaIO4*3H2O from water;;
In neat (no solvent) byproducts: H2O; at 34.5°C;;
In water formation by recrystallization of NaIO4*3H2O from water;;

sodium orthoperiodate + periodic acid (13444-71-8) → sodium periodate (7790-28-5)

Conditions	Yield
In further solvent(s) dissolving Na2H3IO6 in pure HIO4; saturation of the solution; evaporation;;
In further solvent(s) dissolving Na2H3IO6 in pure HIO4; saturation of the solution; evaporation;;

potassium metaperiodate (7790-21-8) → sodium periodate (7790-28-5)

Conditions	Yield
In not given hot KIO4 (6 %) soln. used, cation exchange;

sodium iodate + chlorine (7782-50-5) + sodium hydroxide (1310-73-2) → sodium periodate (7790-28-5) + sodium iodate chloride * 9 H2O

Conditions	Yield
In not given complete crystallization of NaIO4 on passing Cl2 into a solution of NaIO3 and NaOH; crystallization of 2NaIO3*3NaCl*9H2O after complete precipitation of NaIO4;;
In not given complete crystallization of NaIO4 on passing Cl2 into a solution of NaIO3 and NaOH; crystallization of 2NaIO3*3NaCl*9H2O after complete precipitation of NaIO4;;

sodium periodate trihydrate → sodium periodate (7790-28-5) + water (7732-18-5)

Conditions	Yield
In neat (no solvent) dehydration over H2SO4 or on heating at 100 °C;;
In neat (no solvent) dehydration over H2SO4 or on heating at 100 °C;;

sodium iodate → sodium periodate (7790-28-5)

Conditions	Yield
With ozone; sodium hydroxide at 20℃; for 1h; pH=13; pH-value;

sodium periodate (7790-28-5) + 3-(trimethylstannyl)propyl ethyl sulfide (104336-12-1) → 3-(trimethylstannyl)propyl ethyl sulfoxide (104336-13-2)

Conditions	Yield
In methanol; water slow addn. of NaIO4 (in H2O) to Sn-compd. (in MeOH) at 0°C, stirring (0°C, 5 h; then room temp., 18 h); filtration, solvent removal (reduced pressure), distn.; elem. anal.;	99%

sodium periodate (7790-28-5) + trans-dichlorobis(ethylenediamine)cobalt(III) chloride (13408-72-5, 14040-32-5, 14040-33-6, 20594-10-9, 20594-11-0) → trans-dichlorobis(ethylenediamine)cobalt(III) periodate (14587-93-0, 92276-03-4)

Conditions	Yield
In water byproducts: NaCl; the soln. of complex in water was mixed with a soln. of NaIO4 in min water; ppt. was dried in air; elem. anal.;	99%

hydrogenchloride (7647-01-0) + sodium periodate (7790-28-5) + (2,7-di-tert-butyl-5-[4-(methoxycarbonyl)phenyl]-9,9-dimethyl-9H-xanthen-4-yl)boronic acid pinacol ester + water (7732-18-5) → (2,7-di-tert-butyl-5-[4-(methoxycarbonyl)phenyl]-9,9-dimethyl-9H-xanthen-4-yl)boronic acid

Conditions	Yield
Stage #1: sodium periodate; (2,7-di-tert-butyl-5-[4-(methoxycarbonyl)phenyl]-9,9-dimethyl-9H-xanthen-4-yl)boronic acid pinacol ester; water In tetrahydrofuran at 20℃; for 0.5h; Schlenk technique; Inert atmosphere; Stage #2: hydrogenchloride In tetrahydrofuran; water at 20℃; for 12h;	95%

sodium periodate (7790-28-5) + ruthenium trichloride hydrate + tetrapropylammonium hydroxide → tetrapropylammonium perruthennate (114615-82-6)

Conditions	Yield
In water stirring of hydrated RuCl3 and NaIO4 in H2O overnight; addn. to an aq. soln. of n-Pr4NOH containing NaOH at 0-5°C under an atmosphere of O2;; ppt. was removed every 20 min, washed with ice-cold water, and dried under vac.;;	87%

sodium periodate (7790-28-5) + ruthenium trichloride hydrate → hexasodium trans-dioxobis{periodato(4-)-O1O2} rhutenate(VI) *18H2O

Conditions	Yield
In sodium hydroxide aq. NaOH; saturated soln. of NaIO4 was added to soln of RuCl3 in aq. NaOH; filtered, washed with NaOH soln., dried, recrystd. from aq. NaOH, washed with NaOH, elem. anal.;	85%

sodium periodate (7790-28-5) + {CoCO3phan2}Cl*H2O → {CoCO3phan2}IO4

Conditions	Yield
In water byproducts: NaCl; a soln. of Co-complex and NaIO4 in water were mixed, allowed to stand for three hours at room temp.; crystals were collected and dried in air; elem. anal.;	85%

sodium periodate (7790-28-5) + (2,2'-biimidazole(1-))bis(1,10-phenanthroline)cobalt(III)dichloride decahydrate → (2,2'-biimidazole(1-))bis(1,10-phenanthroline)cobalt(III)diperiodate hemihydrate

Conditions	Yield
In water aq. soln. of NaIO4 added to aq. soln. of complex (2:1 mol); product crystd. (MeCN-H2O) at room temp. for 2 d; filtered off; dried inair; elem. anal.;	85%

sodium periodate (7790-28-5) + osmium(VIII) oxide (20816-12-0) + C39H52N8Zn → C35H44N8OZn

Conditions	Yield
With polyvinylpyridine In tetrahydrofuran; water at 20℃; for 16h;	85%

sodium periodate (7790-28-5) + Betulinic acid (472-15-1) → platanic acid (6060-06-6)

Conditions	Yield
Stage #1: Betulinic acid With osmium(VIII) oxide In 1,4-dioxane; water at 20℃; for 1h; Stage #2: sodium periodate In 1,4-dioxane; water at 20℃; for 72h;	81.3%

sodium periodate (7790-28-5) + mannitol (69-65-8) + 2,2-dimethoxy-propane (77-76-9) → 2,3-isopropylidene-glyceraldehyde (15186-48-8)

Conditions	Yield
Stage #1: mannitol; 2,2-dimethoxy-propane With tin(ll) chloride Stage #2: sodium periodate	76%

sodium periodate (7790-28-5) + tris(1,10-phenanthroline)cobalt(III) chloride + water (7732-18-5) → tris(1,10-phenanthroline)cobalt(III) periodate dihydrate

Conditions	Yield
In water aq. solns. of cobalt complex and sodium salt mixed; solid filtered off, washed with cold water, alcohol, dried in air; elem.anal.;	75%

sodium periodate (7790-28-5) + C4H4O2(CH3)2C6H8NN(CH3)2 (99474-79-0) + 5-Iodo-2-trimethylstannylpent-1-ene (99474-78-9) → C4H4O2(CH3)2C6H7(O)((CH2)3C(Sn(CH3)3)CH2) (99474-81-4)

Conditions	Yield
With lithium diisopropyl amide In tetrahydrofuran alkylation at room temp. for 8 h followed by addn. of 2 equiv. of NaIO4at pH 7 at room temp. (12 h);	70%

sodium periodate (7790-28-5) + sodium molybdate dihydrate (7631-95-0) + choline chloride (67-48-1) + water (7732-18-5) → 2[(CH3)3NC2H4OH](1+)*H3O(1+)*2Na(1+)*7H2O*IMo6O24(5-)=[(CH3)3NC2H4OH]2(H3O)[Na2(H2O)6][IMo6O24]*H2O

Conditions	Yield
With urea In acetic acid Mo compd. added to a eutectic mixt. of N compds., stirred, I compd. added, solvents added, stirred for 4 h at room temp.; filtered, kept at room temp. for 3 d, crysts. filtered, washed (abs. alcohol), dried (vac., 80°C, 0.5 h); elem. anal., powder XRD, TGA;	64%

sodium periodate (7790-28-5) + acetylferrocene (1271-55-2) → ferrocenecarboxylic acid (1271-42-7)

Conditions	Yield
In water all manipulations under inert atm.; aq. soln. of Na salt added to solid complex, stirred for 8 h at room temp.; filtered, washed with water, filtrate acified with glacial AcOH, pptd. with Na2S2O5, dried;	63%

sodium periodate (7790-28-5) + [iridium(I)(1,5-cyclooctadiene){(MeIm)2CHCOO}] + water (7732-18-5) → [iridium(III)(hydroxo)(1,5-cyclooctadiene){(MeIm)2CHCOO}](IO3)

Conditions	Yield
for 0.25h; Schlenk technique; Inert atmosphere;	63%

sodium periodate (7790-28-5) + 1,10-Phenanthroline (66-71-7) + potassium osmate (77347-87-6) → [OsO2(1,10-phenanthroline)(IO3(OH)3)]

Conditions	Yield
In water; acetone addn. of phenanthroline to soln. of Os-compd. in 50% Me2CO, stirring, addn. of aq. NaIO4 (pptn.); elem. anal.;	57%

sodium periodate (7790-28-5) + ((CHC4N(CH3)(CH2CH2CO(O)CH3))2CHC4NH(CH3)CHC4N(CHCH3)(CH3)(CH2C(O)N(CH3)2))Zn → ((CHC4N(CH3)(CH2CH2C(O)OCH3))2CHC4NH(CH3)CHC4N(O)(CH3)(CH2C(O)N(CH3)2))Zn (144320-57-0)

Conditions	Yield
With K2CO3; KMnO4 In water; tert-butyl alcohol room temp., 30 min; flash chromy. (silica gel, CH2Cl2/methyl acetate (6+1)), crystd. (CHCl3/n-hexane);	56%

sodium periodate (7790-28-5) + 1-methyl-6-vinyl-benzimidazole (813449-02-4) → 1-methyl-1H-benzo[d]imidazole-6-carbaldehyde (181867-19-6)

Conditions	Yield
With osmium(VIII) oxide In 1,4-dioxane; water at 20℃; for 3h;	55%

sodium periodate (7790-28-5) + sodium carbonate (497-19-8) + molybdenum(VI) oxide → Na5(IMo6O24)*16H2O + carbon dioxide (124-38-9)

Conditions	Yield
In water addn. of MoO3 and Na2CO3 to slurry of NaIO4, boiling, filtration off of traces unreacted MoO3, crystn. on slow evapn.; recrystn. (hot water); elem. anal.;	A 55% B n/a

sodium periodate (7790-28-5) + betulonic acid (4481-62-3) → 3,20-dioxo-29-norlupan-28-oic acid

Conditions	Yield
Stage #1: betulonic acid With osmium(VIII) oxide In 1,4-dioxane; water at 20℃; for 1h; Stage #2: sodium periodate In 1,4-dioxane; water at 20℃; for 72h;	50.3%

ruthenium(IV) oxide + sodium periodate (7790-28-5) → [RuO2(2,2'-bipyridyl)(IO3(OH)3)]

Conditions	Yield
With water; 2,2'-bipyridyl In water; acetone addn. of NaIO4 to aq. suspn. of RuO2, addn. to 2,2'-bipyridine (in 50% aq. Me2CO), stirring (room temp.; pptn.); elem. anal.;	48%

sodium periodate (7790-28-5) + iodine pentoxide (12029-98-0) + copper(II) choride dihydrate + ethanol (64-17-5) + 1,4-diazabicyclo[2.2.2]octane hexahydrate → (N,N'-diethyl-1,4-diazabicyclo-[2.2.2]octane)2[Cu4I8]

Conditions	Yield
With hydrogenchloride; sodium carbonate In water at 180℃; for 120h; Autoclave; High pressure;	48%

sodium periodate (7790-28-5) + potassium osmate (77347-87-6) → [OsO2(2,2'-bipyridyl)(IO3(OH)3)] * 1.5H2O

Conditions	Yield
With 2,2'-bipyridyl In water; acetone addn. of bipy to soln. of Os-compd. in 50% Me2CO, stirring, addn. of aq. NaIO4 (pptn.); elem. anal.;	40%

sodium periodate (7790-28-5) + ruthenium(III) chloride trihydrate + tetrapropylammonium hydroxide (4499-86-9) → tetrapropylammonium perruthennate (114615-82-6)

Conditions	Yield
Stage #1: tetrapropylammonium hydroxide With sodium hydroxide In water Stage #2: sodium periodate; ruthenium(III) chloride trihydrate In water at 20℃; for 16h;	33%

ruthenium(IV) oxide + sodium periodate (7790-28-5) + orthotelluric acid (7803-68-1) → [RuO2(2,2'-bipyridyl)(TeO2(OH)4)] (172267-60-6)

Conditions	Yield
With water; 2,2'-bipyridyl In water; acetone addn. of NaIO4 to aq. suspn. of RuO2, addn. to mixt. of 2,2'-bipyridineand Te(OH)6 (in 50% aq. Me2CO), stirring (room temp., 5 min; pptn.); elem. anal.;	29%

sodium periodate (7790-28-5) + di(pyridin-2-yl)amine (1202-34-2) + potassium osmate (77347-87-6) → [OsO2(2,2'-dipyridylamine)(IO3(OH)3)]

Conditions	Yield
In water; acetone addn. of ligand to soln. of Os-compd. in 50% Me2CO, stirring, addn. of aq. NaIO4 (pptn.); elem. anal.;	28%

sodium periodate (7790-28-5) + λ-α,β-bidentate Cr(H2O)4ADPαS + aniline hydrochloride (142-04-1) → Cr(H2O)4PPS

Conditions	Yield
With mercaptoethyl alcohol oxidn. with NaIO4 at pH 6 for 5 min, then addn. of mercaptoethanol for 5 min., then β-elimination with aniline hydrochloride soln. (pH 5); purifn. on a Dowex-50 ( H(1+)) column by using water as eluant;	20%

Upstream product

• 7553-56-2 iodine 
• 1310-73-2 sodium hydroxide 
• 7782-50-5 chlorine 
• 7681-82-5 sodium iodide 
• 13444-71-8 periodic acid 
• 7790-21-8 potassium metaperiodate 
• 7757-82-6 sodium sulfate 

Downstream Products

• 20427-56-9 ruthenium tetroxide 
• 7553-56-2 iodine 
• 64-18-6 formic acid 
• 86012-02-4 (C₆H₅)3SnCH₂CH₂S(O)C₆H₄CH₃ 
• 66868-68-6 4-(2-methylpropyl)sulfinyl-2-nitroaniline 
• 56723-36-5 4-bromo-2,5-diisopropylphenyl methyl sulfoxide 
• 87130-01-6 4-(2-methoxyethyl)-phenoxy-acetaldehyde 
• 146531-62-6 rac-p-[[5-(o-methoxybenzyl)-6-[2-[(tetra-hydro-2H-pyran-2-yl)oxy]ethoxy]-4-pyrimidinyl]sulfamoyl]-benzaldehyde 
• 841302-90-7 (3-Fluoro-6-methoxy-4-quinolinyl)acetaldehyde 
• 181867-19-6 1-methyl-1H-benzo[d]imidazole-6-carbaldehyde 
• 114615-82-6 tetrapropylammonium perruthennate 
• 6060-06-6 platanic acid 

Relevant academic research and scientific papers

Regeneration of Aqueous Periodate Solutions by Ozone Treatment: A Sustainable Approach for Dialdehyde Cellulose Production

A method for easy and fast regeneration of aqueous periodate solutions from dialdehyde cellulose (DAC) production by ozone treatment is presented, along with a direct and reliable simultaneous quantification of iodate and periodate by reversed-phase HPLC. The influence of iodate and ozone concentration, solution pH, and reaction time on the regeneration efficiency was studied, as well as the reaction kinetics. Regeneration of spent periodate solutions by ozone was successfully performed in alkaline medium, which favors the formation of free .OH radicals, as supported by the addition of radical scavengers and quantum mechanical calculations. At pH 13 and an ozone concentration of approximately 150 mg L-1, periodate was completely regenerated from a 100 mm solution of iodate within 1 h at room temperature. A cyclic process of cellulose oxidation and subsequent regeneration of spent periodate with 90 % efficiency has been developed. So far, commercial applications of DAC have been hampered by difficulties in reusing the costly periodate. This work overcomes this hurdle and presents a highly efficient, clean, and low-cost protocol for the preparation of DAC with integrated periodate recycling, with the possibility of scaling the process up.

Polymer-drug conjugates comprising hydrazide linkers

Carriers for drug delivery, methods of making such carriers and for associating them to drugs, the resulting carrier and drug combination and methods for drug delivery, particularly controlled or sustained release delivery, using such carrier and drug combinations.

Hydrogels and water soluble polymeric carriers for durg delivery

Carriers for drug delivery, methods of making such carriers and for associating them to drugs, the resulting carrier and drug combination and methods for drug delivery, particularly controlled or sustained release delivery, using such carrier and drug combinations.

5'ESTs for secreted proteins expressed in various tissues

The sequences of 5' ESTs derived from mRNAs encoding secreted proteins are disclosed. The 5' ESTs may be used to obtain cDNAs and genomic DNAs corresponding to the 5' ESTs. The 5' ESTs may also be used in diagnostic, forensic, gene therapy, and chromosome mapping procedures. Upstream regulatory sequences may also be obtained using the 5' ESTs. The 5' ESTs may also be used to design expression vectors and secretion vectors.

5' ESTs for secreted proteins expressed in various tissues

The sequences of 5' ESTs derived from mRNAs encoding secreted proteins are disclosed. The 5' ESTs may be used to obtain cDNAs and genomic DNAs corresponding to the 5' ESTs. The 5' ESTs may also be used in diagnostic, forensic, gene therapy, and chromosome mapping procedures. Upstream regulatory sequences may also be obtained using the 5' ESTs. The 5' ESTs may also be used to design expression vectors and secretion vectors.

5' ests for secreted proteins expressed in muscle and other mesodermal tissues

The sequences of 5' ESTs derived from mRNAs encoding secreted proteins are disclosed. The 5' ESTs may be used to obtain cDNAs and genomic DNAs corresponding to the 5' ESTs. The 5' ESTs may also be used in diagnostic, forensic, gene therapy, and chromosome mapping procedures. Upstream regulatory sequences may also be obtained using the 5' ESTs. The 5' ESTs may also be used to design expression vectors and secretion vectors.

Method for production of halogen-containing aromatic compound

This invention relates to a method for the production of an aromatic compound (II) having a (CH2)nCX2Br group (wherein X represents a fluorine or chlorine atom and the X's may be same or different, and n is an integer in the range of 0 to 4) by the reaction of photo-bromination of an aromatic compound (I) having a (CH2)nCX2H group (wherein X and n are as defined above) with a brominating agent, wherein the photo-bromination reaction is carried out while removing hydrogen bromide generated in the reaction system and/or in an atmosphere of a low oxygen content, and a halogen-containing naphthalene compound represented by the following formula (1): wherein Y represents —CF2H, —CF2Br, or —CHO group, Z1and Z2independently represent a halogen atom, and p and q independently are an integer in the range of 0 to 3.

PROBE FOR USE IN NUCLEIC ACID ANALYSIS AND DETECTING METHOD

A probe for detecting nonradioactive nucleic acids by the hybridization technique, and a highly sensitive and highly selective method for the detection. The probe comprises a set of two or more oligonucleotide probes that can hybridize perfectly complementarily with the specific portion of the sequence of the consecutive bases of the target nucleic acid, each oligonucleotide probe being labeled at the 5' or 3' end thereof with a chromophoric group having a suitable spatial arrangement so that adjacent chromophoric groups can yield an excimer or the like when each probe hybridizes with the target nucleic acid. More specifically, although the probe of the invention comprises a set of two or more labeled probes and the labeling groups to be detected are present each on a different probe, the labeling groups take such a spatial arrangement that the two chromophoric groups present on the two probes which have come to exist adjacent to each other only after the hybridization with the target nucleic acid induce unique phenomena such as excimer fluorescence, thereby enabling the target nucleic acid to be detected with a high recognizability. Thus the probe of the invention enables the erroneous recognition which has been problematic heretofore to be reduced remarkably and the types of utilizable labeling groups to be varied widely. Further it is possible to improve the detection sensitivity remarkably because it is possible to reduce the background noise remarkably. In addition, it is possible to discriminate a number of (single-base variation) nucleic acids that are different from one another in only one base present at a specific position to be detected, which has been difficult heretofore.

Synthesis of 19-nor vitamin D compounds

A convergent synthesis of 19-nor-vitamin D compounds, specifically 19-nor-1α,25-dihydroxyvitamin D3, is disclosed. The synthesis can also readily be utilized for preparing other 1α-hydroxylated 19-nor-vitamin D compounds. The key step in the synthesis is a suitable application of Lythgoe's procedure i.e. a Horner-Wittig reaction of the lithium anion of a phosphine oxide with a Windaus Grundmann ketone to give, after any necessary deprotection, the desired 19-nor-vitamin D compound.